-
-
-
-
-
-
-
CytomX Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
-
-
-
-
-
-
CytomX Therapeutics (CTMX) PT Raised to $2.50 at Jefferies, 'EGFRxCD3 on Track for Ph1a Data in 2H24'
-
-
-
-
-
-
-
Jefferies Downgrades CytomX Therapeutics (CTMX) to Hold
-
-
-
-
-
-
-
CytomX to Present at the Jefferies 2017 London Healthcare Conference
-
-
-
-
-
-
-
CytomX Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
-
-
-
-
-
72,064 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

